
- Telehealth Visits
- Insurance plan information


Nikki Padilla, MS
She | Her | HersMedical Genetics- Telehealth Visits
- Insurance plan information




Nikki Padilla, MS
She | Her | HersMedical Genetics- Telehealth Visits
- Insurance plan information
On this page
About me
Nikki Padilla is a genetic counselor who educates families about genetic conditions, inheritance patterns and genetic testing. She specializes in pediatric and biochemical (body enzyme-related) genetics, and is part of the newborn screening program. Her goals are to communicate complex information in ways that nonmedical people can understand and to help them through what is often a challenging time. Knowing that a genetic diagnosis affects different people differently, she strives to provide care centered on the needs and values of individuals. She is fascinated by the ever-changing field of genetics and loves being able to apply current knowledge for the benefit of patients and families.
Padilla earned her master's degree in genetic counseling at the University of California, Irvine.
Outside of work, Padilla focuses on being present in the lives of her friends and family, including her three children. She is a big sports fan at all levels, from her kids' teams to professional leagues. She also enjoys staying physically active, playing the piano and baking.
Education & training
Board certification
- Pediatric Genetics, American Board of Genetic Counseling
Degree
- MSGC-1, University of California, Irvine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%225153%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225153%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.